The rVSV-EBOV vaccine provides limited cross-protection against Sudan virus in guinea pigs

Recombinant vesicular stomatitis viruses (rVSVs) engineered to express heterologous viral glycoproteins have proven to be remarkably effective vaccines. Indeed, rVSV-EBOV, which expresses the Ebola virus (EBOV) glycoprotein, recently received clinical approval in the United States and Europe for its...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Wenguang, He, Shihua, Liu, Guodong, Schulz, Helene, Emeterio, Karla, Chan, Michael, Tierney, Kevin, Azaransky, Kim, Soule, Geoff, Tailor, Nikesh, Salawudeen, Abdjeleel, Nichols, Rick, Fusco, Joan, Safronetz, David, Banadyga, Logan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257645/
https://www.ncbi.nlm.nih.gov/pubmed/37301890
http://dx.doi.org/10.1038/s41541-023-00685-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257645/
https://www.ncbi.nlm.nih.gov/pubmed/37301890
http://dx.doi.org/10.1038/s41541-023-00685-z

Ejemplares similares